Overview

PF-04995274 and Emotional Processing in Treatment Resistant Depression

Status:
Unknown status
Trial end date:
2020-04-30
Target enrollment:
Participant gender:
Summary
This study will test whether seven days adjunctive administration of a serotonin receptor subtype 4 (5HT4) agonist called PF-04995274 has positive effects on emotional processing and neural activity in medicated, treatment-resistant depressed patients compared to placebo.
Phase:
Phase 1
Details
Lead Sponsor:
University of Oxford